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ARTICLE
Disease-relevant transcriptional signatures
identiﬁed in individual smooth muscle cells from
healthy mouse vessels
Lina Dobnikar1,2, Annabel L. Taylor 2, Joel Chappell2, Phoebe Oldach1,6, Jennifer L. Harman2, Erin Oerton 1,7,
Elaine Dzierzak3, Martin R. Bennett1, Mikhail Spivakov 1,4,5 & Helle F. Jørgensen 2
Vascular smooth muscle cells (VSMCs) show pronounced heterogeneity across and within
vascular beds, with direct implications for their function in injury response and athero-
sclerosis. Here we combine single-cell transcriptomics with lineage tracing to examine VSMC
heterogeneity in healthy mouse vessels. The transcriptional proﬁles of single VSMCs con-
sistently reﬂect their region-speciﬁc developmental history and show heterogeneous
expression of vascular disease-associated genes involved in inﬂammation, adhesion and
migration. We detect a rare population of VSMC-lineage cells that express the multipotent
progenitor marker Sca1, progressively downregulate contractile VSMC genes and upregulate
genes associated with VSMC response to inﬂammation and growth factors. We ﬁnd that Sca1
upregulation is a hallmark of VSMCs undergoing phenotypic switching in vitro and in vivo,
and reveal an equivalent population of Sca1-positive VSMC-lineage cells in atherosclerotic
plaques. Together, our analyses identify disease-relevant transcriptional signatures in VSMC-
lineage cells in healthy blood vessels, with implications for disease susceptibility, diagnosis
and prevention.
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Vascular smooth muscle cell (VSMC) accumulation is ahallmark of cardiovascular diseases such as atherosclerosisthat causes heart attack and stroke1. VSMCs are found
within the medial layer of large blood vessels, provide mechanical
strength to the vessel and regulate vascular tone to control blood
ﬂow and blood pressure. VSMCs within healthy vessels are
quiescent and characterised by the expression of contractile
proteins such as aSMA (also known as ACTA2), Myocardin
(MYOCD) and SM-MHC (also known as MYH11). However,
VSMCs display remarkable phenotypic plasticity. When stimu-
lated by injury or inﬂammation, VSMCs downregulate expression
of the genes responsible for contractility and acquire a phenotype
characterised by increased extracellular matrix production,
migration and proliferation2,3.
VSMC heterogeneity within and between different vascular
regions with regard to morphology, growth characteristics and
expression of speciﬁc candidate genes has been identiﬁed pre-
viously4. The observed cell-to-cell variation might result from
different vascular structure and blood ﬂow5,6, as well as from the
distinct developmental origin of VSMCs in different vascular
beds7. It has therefore been hypothesised that VSMCs displaying
different levels of plasticity co-exist within the healthy vessel wall3
and might contribute to the non-random disease susceptibility of
individual parts of the vasculature. We and others recently
demonstrated that VSMC accumulation in atherosclerosis and
after injury results from extensive clonal expansion of a small
number of VSMCs8–10. This suggests that cells undergoing
expansion were originally different from the general VSMC
population in the healthy vessel wall, highlighting a possible
functional signiﬁcance of VSMC heterogeneity.
Single-cell RNA-sequencing (scRNA-seq) enables genome-
wide proﬁling of individual cells11,12 and is therefore an ideal
methodology to detect cellular heterogeneity in an unbiased
manner. Here we combine different scRNA-seq methodologies to
delineate VSMC heterogeneity in healthy arteries and provide
global insight into the nature of distinct cell subsets. We show
that while the contractile VSMC signature is expressed relatively
uniformly across most cells, there are pronounced differences in
single-VSMC expression proﬁles between and within vascular
beds for genes involved in cell adhesion, migration and inﬂam-
mation. Combining scRNA-seq with VSMC lineage tracing, we
reveal a rare subset of VSMC-lineage cells expressing Stem Cell
Antigen 1 (Sca1, encoded by Ly6a, referred to below as Ly6a/
Sca1). Sca1-positive cells show progressive downregulation of
contractile VSMC genes and increased expression of genes
associated with wound healing, migration and activation of
growth factor signalling. We provide experimental evidence
indicating that upregulation of Sca1 is a hallmark of VSMCs
undergoing phenotypic switching in vivo and detect an equivalent
Sca1-positive cell population within atherosclerotic plaques.
These results suggest that Sca1 marks a plastic VSMC sub-
population that gives rise to functionally distinct cells in disease.
Results
Single-cell transcriptomes of vascular smooth muscle cells. To
delineate VSMC heterogeneity in healthy tissue, we initi-
ally generated transcriptional proﬁles of individual cells using
Fluidigm C1 technology. Single cells were isolated from the
medial layer of mouse aortas by enzymatic digestion (Fig. 1a) and
processed for sequencing. The scRNA-seq proﬁles of 143 cells
from four experiments passed stringent quality control (83% of
the analysed cells; Supplementary Fig. 1; see Methods for details).
On average, 6704 genes were detected per cell.
All analysed cells showed consistently high expression of the
contractile VSMC markers Myh11, Acta2 and Tagln. Lower-
expressed marker genes Myocd, Smtn, Vcl and Cnn1 were
detected in most cells, similar to what was observed for
housekeeping genes (Fig. 1b). This indicates that all medial cells
analysed express a contractile VSMC signature. Consistent with
this conclusion, principal component analysis (PCA) demon-
strated that all analysed single cells clustered tightly with VSMC
control samples and away from adventitial control samples, both
generated using the tube control protocol (Fig. 1c). Furthermore,
the pooled single-cell VSMC expression proﬁles correlated with
bulk RNA-seq data (R2= 0.51; Fig. 1d). As expected, the scRNA-
seq proﬁles of ex vivo cells were clearly distinct from published
proﬁles of cultured VSMCs13 (Fig. 1e), which are known to
recapitulate some aspects of VSMC phenotypic switching14. In
particular, ex vivo cells expressed higher levels of contractile
genes compared with the cultured cells (Supplementary Fig. 2).
Taken together, these results conﬁrm that the single-cell datasets
we have generated are of sufﬁcient coverage, speciﬁcity and overall
quality to unambiguously identify the proﬁled cells as contractile
VSMCs.
Regional differences in VSMC gene expression. We applied
single-cell transcriptomics to gain insight into the previously
observed VSMC heterogeneity between the athero-prone aortic
arch (AA) and the more disease-resistant descending thoracic
aorta (DT)15,16. AA and DT VSMCs differ in expression of a
number of genes, including posterior Hox genes and other tran-
scription factors15. These differences may arise from the distinct
embryonic origins of VSMCs in the AA (neural crest) and DT
(mesoderm) regions7. Alternatively, VSMCs in both regions
could be heterogeneous with respect to these genes, with speciﬁc
cell subsets represented in different proportions in the AA
compared with the DT. These scenarios can be addressed directly
with scRNA-seq. Prior to analysing regional expression differ-
ences at the single-cell level, we generated bulk RNA-seq proﬁles
of VSMCs isolated from the medial layer of AA and DT to deﬁne
robust gene expression signatures associated with VSMCs from
these regions at the population level, which informed single-cell
analysis (Fig. 2a). In total, 442 genes showed signiﬁcant differ-
ential expression (p < 0.01, log2 fold change > 1), of which 386
genes were upregulated in the AA and 56 genes in the DT (Fig. 2b
and Supplementary Data 1). RT-qPCR in independent, paired AA
and DT samples veriﬁed differential expression of 6 out of 6 genes
tested (Dcn, Lum, Pde1c, Gpc3, 3632451O06Rik and Hoxa7;
Fig. 2c). Overall, 88/442 genes identiﬁed as region-speciﬁc by
RNA-seq were previously found to be differentially expressed in
AA and DT VSMCs by microarray analysis15. Notably, 44% of
the microarray-identiﬁed genes were lowly expressed (normalised
log2-transformed read count < 4) and their regional speciﬁcity
was less reproducible by RNA-seq compared with genes expres-
sed at higher levels (Supplementary Fig. 3). Similar to previous
reports15,16, the genes upregulated in the DT population com-
pared with the AA included many developmental regulators,
including 15 Hox genes corresponding to a posterior identity, and
were signiﬁcantly enriched for the gene ontology (GO) terms
“anterior/posterior pattern speciﬁcation” and “regionalisation and
developmental process” (Supplementary Data 2a). In contrast,
genes upregulated in AA VSMCs were enriched for terms asso-
ciated with immune response, cell proliferation and migration
(for example Lbp, Tgfbi and Mmp12; Fig. 2b and Supplementary
Data 2b), consistent with the increased response of AA cells to
mitogens and inﬂammatory cytokines7,17. Additionally, genes
typically associated with the synthetic VSMC phenotype (Spp1,
Pde1c)3,18 were expressed at higher levels in the AA compared
with the DT VSMCs (Fig. 2b). In summary, population-level
analysis of VSMC region-speciﬁc transcription identiﬁed
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Fig. 2 Bulk RNA-seq of VSMCs from the aortic arch and descending thoracic aorta. a Schematic representation of the aorta, indicating the aortic arch (AA)
and descending thoracic aorta (DT). b Volcano plot showing signiﬁcance (-log10 p-value) versus relative gene expression in VSMCs from the DT versus the
AA. Genes showing signiﬁcant differences in expression (adjusted p-value < 0.01, log2 fold change > 1) are labelled in yellow (upregulated in DT) and red
(upregulated in AA). Gene names for selected genes are indicated. Three independent samples were analysed for each region (AA and DT samples
paired). c Relative expression (log2(DT/AA)) of selected genes determined by RT-qPCR (black dots/bars, n= 4) and bulk RNA-seq (grey dots/bars). Error
bars indicate s.e.m. from four independent RT-qPCR experiments. Rik*: 3632451O06Rik
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Fig. 1 Single-cell RNA-seq analysis of vascular smooth muscle cells. a Schematic of the approach. Cells from the medial layer are enzymatically digested to
obtain a single-cell suspension. Single-cell cDNA libraries are then generated, followed by sequencing and data analysis. b Violin plots showing the log2-
transformed normalised expression of VSMC marker genes across the proﬁled 143 cells (top), as well as of housekeeping genes with similar mean
expression levels (lower panel). c Mapping of single-cell VSMC transcriptomes (light blue), as well as transcriptomes from control VSMC (Sca1–, dark
blue) and adventitial (Adv) cell (Sca1–, orange; Sca1+, red) samples (tube controls) on a two-dimensional PCA space. d Dot plot showing the log2-
transformed read counts detected for each gene (black dots) when pooling across all single-cell samples versus the read counts detected with bulk RNA-
seq. The dashed line shows a linear regression ﬁt. e PCA plot summarising the single-cell expression proﬁles for ex vivo VSMCs (blue) and in vitro cultured
VSMCs (green, data from Gene Expression Omnibus accession GSE79436, Adhikari et al.13)
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molecular determinants that may underlie the reported regional
differences in VSMC growth factor response and disease
susceptibility.
Vascular region identity manifests in individual VSMCs. The
scRNA-seq dataset described above (Fig. 1) comprised 79 AA and
64 DT cells, allowing comparison of the transcriptional signatures
associated with VSMCs from these regions at a single-cell level.
Consistent with the region-speciﬁc gene signatures identiﬁed by
bulk expression analysis, genes such as Pde1c and Hand2 were
almost exclusively detected in cells from the AA region and
Hoxa7 in cells from the DT region (Fig. 3a, top panel). However,
other genes showing region-dependent expression levels in the
bulk analysis were expressed at similar levels in a subset of cells
from both regions, while the number of expressing cells was
greater in either the DT (Tnc, Calcrl) or AA region (Aspn, Gpc3)
(Fig. 3a, lower panel). Therefore, the observed region-speciﬁc
gene signatures could reﬂect the presence of different proportions
of cells expressing these genes in each region. Alternatively, and
not mutually exclusively with the above, each individual VSMC
may bear an inherent regional signature.
To distinguish between these possibilities, we investigated
whether VSMC regional identity can be reliably predicted from
single-cell proﬁles. To this end, we employed random forest19
(RF) analysis (Fig. 3b), a nonparametric tree-based machine
learning method that is widely used for classiﬁcation based on
expression data, including scRNA-seq20,21. First, 25% of cells
were randomly selected and set aside for the ﬁnal testing of the
prediction algorithm. Data for the remaining 108 cells was used to
rank differentially expressed genes detected in the bulk RNA-seq
analysis, based on their power to predict regional identity in
individual cells. The inﬂuence of each of the top 30 predictive
genes on RF classiﬁcation accuracy is shown in Fig. 3c and
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Fig. 3 Single-VSMC transcriptomes reﬂect regional identity. a Boxplots showing log2-transformed normalised expression of genes detected as differentially
expressed between the aortic arch (AA, red) and descending thoracic aorta (DT, yellow) in bulk RNA-seq experiments across single VSMCs. Top panel:
genes showing expression near-exclusively in cells from one tissue. Lower panel: genes that are expressed in different proportions of cells from the AA and
DT. Median (centre line), ﬁrst and third quartiles (bounds of box) and 1.5 interquartile range (whiskers) and individual data points (dots) are indicated.
b Schematic of the random forest analysis. The regional identity of 75% of the cells was used in classiﬁer training and reﬁnement. The remaining 25% of
cells (35 cells) were tested with the model showing the best classiﬁcation performance with the 75% subset. c The out-of-bag mean decrease in
classiﬁcation accuracy for the 30 genes used in the ﬁnal classiﬁer. d ROC curve showing the performance of the classiﬁer on the 25% subset of cells that
were not used for model testing and reﬁnement. e PCA plot based on the 30 genes used in the ﬁnal classiﬁer, showing AA (red) and DT (yellow) cells.
Cells in the 25% test subset are circled in black
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Supplementary Data 3a. These 30 genes were used in the ﬁnal RF
classiﬁer; using additional genes for classiﬁcation did not
signiﬁcantly increase classiﬁer performance. The resulting RF
model showed very high predictive power on the unseen 25% of
the data, as demonstrated by the ROC curve (Fig. 3d), correctly
classifying 17/18 AA cells and 14/15 DT cells set aside for model
testing (Supplementary Data 3b). Consistent with this, a PCA plot
based on the 30 RF classiﬁer genes showed a clear segregation of
AA from DT cells (Fig. 3e). The highly robust performance of the
scRNA-seq-based classiﬁer strongly indicates that features of
regional identity are borne by individual cells, rather than reﬂect
the differential composition of cell populations between the regions.
VSMC heterogeneity within vascular regions. We next exam-
ined whether cells within a speciﬁc vascular region showed
heterogeneity with respect to expression of other genes. To
identify variably expressed genes robustly, we assessed the var-
iance of log-transformed scRNA-seq counts for each gene across
cells, relative to that expected from the estimated technical noise
(modiﬁed from ref.22; Fig. 4a; see Methods for details). We
identiﬁed 113 highly variably expressed genes (HVGs) in AA and
79 HVGs in DT VSMCs (adjusted p-value < 0.05; Supplementary
Data 4ab). Notably, the HVG scores between the two regions
were correlated (r= 0.67; Supplementary Fig. 4a) and only one of
the identiﬁed HVGs (Wif1) was detected as differentially
expressed between the two regions.
Many of the identiﬁed HVGs encode factors that have been
directly linked to VSMC phenotype or have documented roles in
cardiovascular disease, inﬂammation and VSMC biology (Fig. 4b
and Supplementary Data 4c). For example, one of the top HVGs,
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Fig. 4 VSMCs show heterogeneous expression of genes implicated in cardiovascular disease. a Scatter plots showing the mean-variance relationship of
log2-transformed normalised expression levels for each gene, with colour-highlighting of genes showing highly variable expression in the aortic arch (AA,
red, top panel) and descending thoracic aorta (DT, yellow, lower panel). b Bar graph showing the implication of the identiﬁed highly variable genes (HVGs)
in AA (red), DT (yellow) or both regions (green) in functions related to VSMC biology based on published literature (see Methods for details). c Dot plot
showing log2-transformed normalised counts detected in individual VSMCs from AA (red) and DT (yellow) for selected genes that show variable
expression across single cells. d, e t-SNE plot visualising a 10X Chromium dataset generated from 2846 unselected cells (gated as live using Zombie NIR
staining and singlets using doublet discrimination) from the whole aortas of three tamoxifen-labelled Myh11-CreERt2/Confetti animals (pooled). d Clusters
generated using graph-based clustering are colour-coded as indicated and adventitial (Adv), endothelial (EC) and VSMC (VSMC) populations are labelled.
e Log-transformed expression levels of selected HVGs identiﬁed in AA and DT populations based on Fluidigm C1 data (Rgs5, Irf1, Atf3, Nfkbia), shown using
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Rgs5 (Fig. 4c), is induced by PDGF and known to control vaso-
contractility by accelerating the inactivation of Gα-dependent
signalling23. Interestingly, Rgs5 is highly expressed in the
descending aorta compared with the carotid arteries during
development, but this regional difference is lost in adults24.
Consistent with this, we found that Rgs5 is expressed in subsets of
single cells from both AA and DT (Fig. 4c). Other genes showing
heterogeneous expression in at least one region include factors
involved in adhesion and cell migration (such as Adamts1, Gja1
and Sparcl1), as well as inﬂammation (such as Il1r1 and Irf1)
(Fig. 4c).
The robust HVG identiﬁcation strategy employed above
deliberately disfavours genes expressed at high levels in only a
very small number of cells. However, such genes may be relevant
to VSMC biology, given, for example, that only a small number of
cells undergo clonal proliferation in response to injury or in
atherosclerosis8–10. We therefore employed the “Distance to
Median” (DM) method that ranks genes based on the squared
coefﬁcient of variation of gene expression counts given the
mean22,25 (Supplementary Data 5). This method ranked Rgs5
(also identiﬁed using the robust approach) and Vcam1 among the
top HVGs in both AA and DT regions. Vcam1 is expressed in
endothelial cells, but has also previously been detected in
VSMCs26, where it is upregulated in response to pro-
inﬂammatory cytokines27. Notably, another variably expressed
gene highlighted in the DM analysis encodes Stem Cell Antigen 1
(Ly6a/Sca1; ranked within the top 1.2%).
We next assessed the expression of the identiﬁed hetero-
geneously expressed genes in a much larger dataset (~2800 cells)
of dissociated aortic cells generated using 10X Chromium
technology, which has a higher throughput, but reduced coverage
compared with the Fluidigm C1-based analysis presented
above28. As shown in Fig. 4d, t-SNE analysis of this
dataset revealed clusters of arterial cells corresponding to VSMCs,
endothelial and adventitial cell populations based on marker gene
expression (including Myh11/Cnn1, Cdh5 and Pdgfra, respec-
tively, Supplementary Fig. 4b). Myh11-expressing VSMCs further
segregated into seven clusters, highlighting the heterogeneity of
this population. Remarkably, these clusters showed differential
expression of 13% of the HVGs identiﬁed above, including Rgs5,
Irf1, Nfkbia and Adamts1 (22/147, Fisher’s exact test p= 2e−15),
and two genes prioritised using the DM method (Rgs5 and Plaur)
based on Fluidigm C1 data (Fig. 4e, see Methods for details).
Jointly, these analyses demonstrate that region-speciﬁc gene
expression manifests at the level of individual VSMCs and may
directly contribute to disease predisposition of the aortic arch.
Additionally, many genes previously implicated in VSMC
regulation and vascular disease development show cell-to-cell
variation in expression levels in the vessel media. These highly
variable genes could underlie the functional heterogeneity of
VSMCs, such as that observed in atherosclerosis8–10.
A subset of VSMC-lineage cells express Stem Cell Antigen 1.
The Ly6a/Sca1 gene, which marks stem and progenitor cells in
the vasculature29–34 and other tissues35, was identiﬁed as het-
erogeneously expressed in VSMCs with the DM method above
(Supplementary Fig. 5a). Consistent with this, Ly6a/Sca1
expression was detected in individual cells in the VSMC cluster in
the 10X Chromium whole aorta analysis, in addition to the
expected30,36 abundant Ly6a/Sca1 expression in the adventitial
and endothelial clusters (Fig. 5a). Furthermore, 0.5–1% of medial
cells (n > 10) stained positively with anti-Sca1 antibody in ﬂow
cytometry analysis (Supplementary Fig. 5b). To eliminate possible
artefacts from antibody cross-reactivity, we also analysed trans-
genic Sca1-GFP animals, which express GFP from the Ly6a/Sca1
promoter37. Similar to the observations from antibody staining,
0.2–1.6% of medial cells from transgenic animals expressed GFP
(Supplementary Fig. 5c, n= 4). To test whether GFP-expressing
cells from the medial layer of Sca1-GFP animals have a VSMC
identity, we sorted GFP-positive cells from either medial or
adventitial samples and immunostained them for aSMA (a con-
tractile VSMC marker). As expected, none of the 60 analysed
GFP+ cells from the adventitial sample expressed aSMA. In
contrast, 25–86% of medial GFP+ cells stained positive for aSMA
(Fig. 5b, c). Taken together, these results suggest the existence of a
rare subpopulation of Sca1-expressing VSMCs within the medial
layer of healthy animals.
To further conﬁrm the lineage afﬁliation of Sca1+ medial cells,
we analysed Sca1 expression in the aortic media of mouse models
that allow for genetic lineage labelling of VSMCs (Myh11-
CreERt2/EYFP38 and Myh11-CreERt2/Confetti8). These animals
express the tamoxifen-inducible CreERt2 recombinase selectively
in smooth muscle cells under control of the Myh11 promoter.
Activation of the Cre recombinase by tamoxifen administration
therefore causes in VSMC-speciﬁc deletion of a stop cassette at
either single-colour (EYFP) or multicolour reporters (Confetti),
resulting in stable ﬂuorescent protein expression (Fig. 6a). The
speciﬁcity of the lineage label to the media was conﬁrmed by
analysis of 72 arterial sections from six Confetti-labelled animals
(Fig. 6b, c), which detected only seven lineage-positive cells in the
adventitial layer and one cell in the vascular endothelium. In
contrast, recombination was efﬁcient in medial cells (70–95% for
the Confetti reporter and 40–90% for the EYFP reporter, Fig. 6d),
consistent with previous data8. We conﬁrmed by ﬂow cytometry
that a signiﬁcant proportion of Sca1-expressing cells (S+) isolated
from the media of Myh11-CreERt2/EYFP mice expressed the
EYFP lineage label (Fig. 6e). We also detected a small number of
Ly6a/Sca1+ cells in a 10X Chromium analysis of sorted Myh11-
lineage labelled cells (Supplementary Fig. 6a), conﬁrming the
existence of a rare population of Sca1-positive VSMCs in the
media.
Single-cell expression proﬁles of Sca1+ VSMC-lineage cells.
Due to the low frequency of Ly6a/Sca1+ VSMCs, the number of
cells proﬁled using 10X Chromium technology was insufﬁcient
for robust analysis. We therefore index-sorted cells from
tamoxifen-treated Myh11-CreERt2/Confetti animals based on
Sca1 expression and proﬁled their transcriptomes using the
Smart-seq2 protocol (Fig. 7a). To ensure that only single cells
were analysed, we gated for cells expressing only a single colour of
the lineage label (L) and conﬁrmed singlet isolation by confocal
microscopy (Supplementary Fig. 6b). In total, data for 92 Sca1-
positive/lineage-positive cells (S+L+), as well as 27 Sca1-positive/
lineage-negative (S+L-) and 36 “conventional” Sca1-negative/
lineage-positive (S−L+) control cells, from six independent cell
pools proﬁled in three experiments passed stringent quality
control ﬁlters (Supplementary Fig. 6c-e, see Methods for details)
and were used in further analysis.
Ly6a/Sca1 transcripts were only detected in a subset of S+ cells
(41/119, 34%, Fig. 7b), which could be due to either a lower
sensitivity of scRNA-seq compared with FACS analysis or
biological factors such as differences between transcript and
protein stability. While all S−L+ cells expressed Myh11 mRNA,
as expected, S+L+ cells showed a broad range of Myh11
transcript levels (Fig. 7b). Myh11 was also expressed (more than
10 reads) in 6/27 of S+L- cells, suggesting that these cells
represent the fraction of VSMCs that did not successfully
recombine the lineage label after tamoxifen treatment.
Conventional VSMCs (S−L+; Fig. 7c, magenta triangles) and
the majority of non-lineage-labelled Sca1-expressing cells (S+L-;
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blue circles) formed distinct clusters in a PCA based on the levels
of the 500 most variably expressed genes. In contrast, Sca1+
VSMC-lineage cells (S+L+; yellow squares) showed remarkable
heterogeneity, with some S+L+ cells clustering together with
conventional VSMCs, and others spreading away from them.
These ﬁndings provided the initial evidence that VSMC-lineage
Sca1+ cells are distinct from their non-VSMC-lineage counter-
parts and may show heterogeneity with respect to the contractile
VSMC phenotype.
Increased expression of VSMC response genes in Sca1+
VSMCs. To identify gene signatures underlying the observed
heterogeneity of S+L+ cells, we initially employed the robust
HVG method used above for the analysis of the AA and DT
VSMC populations. We identiﬁed 52 genes showing highly
variable expression within the S+L+ population (Supplementary
Fig. 7a,b and Supplementary Data 6), which fell into three net-
work modules according to weighted gene co-expression network
analysis (WGCNA, Fig. 7d and S7c, d). The module showing the
highest level of co-expression consisted of 24 genes, including key
contractile markers (Myh11, Acta2, Tagln and Cnn1; Fig. 7d), and
we will refer to it as the “cVSMC network”. As expected, the
cVSMC network was expressed highly in conventional S−L+
VSMCs, variably across S+L+ cells and at low levels in S+L- cells
(Supplementary Fig. 7e).
The reduced levels of cVSMC markers in a subpopulation of S
+L+ cells that did not cluster with conventional S−L+ VSMCs
(Fig. 7e) prompted us to search for genes that are upregulated as
the contractile identity is lost. We assigned each cell a “cVSMC
score” based on expression of the cVSMC network genes
(Supplementary Data 7; see Methods for details). Using negative
binomial regression, we detected 312 genes whose expression
positively correlated with the cVSMC score in S+L+ cells
(cVSMCpos), and 303 genes showing a negative correlation
(cVSMCneg) (likelihood ratio test, fdr-adjusted p-value < 0.05; see
Methods; Fig. 7f and Supplementary Data 8).
Genes that correlated positively with the cVSMC score were
generally expressed at higher levels in S−L+ cells compared with
S+L- cells and showed variable expression in S+L+ cells (Fig. 7g).
As expected, cVSMCpos genes showed enrichment for ontology
terms describing functional features of contractile VSMCs such as
“muscle contraction” (Tpm1, Mylk), “actin ﬁlament organisation”
(Actn4, Dstn) and “cell-substrate adhesion” (Sdc4, Itgb1) (Fig. 7h
and Supplementary Data 9). In contrast, genes showing a negative
correlation with the cVSMC score (cVSMCneg) were enriched for
ontology terms associated with vascular development, potentially
reﬂecting a less differentiated state compared with contractile
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VSMCs (Fig. 7h)3,39. Consistent with this, cVSMCneg genes
included classical “synthetic” VSMC markers Mgp, Col8a1 and
Spp1 and showed enrichment for terms associated with functional
characteristics of phenotypically switched VSMCs, including
migration (such as Pak3, Igf1 and Igfbp5), proliferation (“cell
growth”, “wound healing”) and secretion of extracellular matrix
components (“vesicle organisation” and “extracellular matrix
structure”) (Fig. 7i and Supplementary Data 9). We also found
enrichment for genes associated with activation of many
signalling pathways (PI3K, small GTPases, Tgf-beta, chemo-
kines), suggesting that the cVSMCneg gene signature reﬂects a
responsive cell state.
Notably, a number of GO terms (including cell adhesion,
migration and ERK1/2 signalling, Fig. 7h) showed enrichment
among both cVSMCpos and cVSMCneg genes. However, we
noted that in these cases the positively and negatively correlated
genes promote different functions within the same broad
pathways. For example, inspection of the focal adhesion pathway
annotated in the KEGG database40 suggested that cVSMCpos
genes enhance stress ﬁbre formation, while cVSMCneg genes
promote cell proliferation (e.g., Pak3, Supplementary Fig. 8a).
Similarly, in the MAPK pathway, genes that correlate positively
with the cVSMC score are generally inhibitory, whereas
negatively correlated genes promote growth factor signalling
(Supplementary Fig. 8b).
Collectively, our ﬁndings demonstrate that S+L+ cells are a
heterogeneous cell population showing progressively lower levels
of contractile VSMC genes (cVSMCpos) and higher expression of
cVSMCneg genes that are associated with responses to diverse
signals.
Sca1 expression is a hallmark of VSMC stimulation. To test
whether Sca1 expression is linked to VSMC phenotypic mod-
ulation, we initially compared levels of Ly6a/Sca1 transcripts in
VSMCs isolated from healthy tissue with cultured VSMCs,
representing a partial model of phenotypic switching. Increased
Ly6a/Sca1 expression in the cultured cells was evident by both
RT-qPCR analysis (Fig. 8a) and in scRNA-seq datasets (Fig. 8b).
The increased Sca1 expression in cultured VSMCs could result
from selective expansion of pre-existing Sca1+ medial cells or
upregulation of Ly6a/Sca1 transcription in contractile VSMCs
upon phenotypic switching. To address this, we sorted Sca1
(GFP)-negative medial cells from Sca1-GFP animals and analysed
GFP expression at different timepoints during in vitro culture. At
day 3, no GFP expression was observed in the medial sample,
while it was abundantly detected in sorted Sca1(GFP)-positive
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adventitial cells (Fig. 8c). However, longer exposure to culture
conditions (7 days and more) induced GFP expression in medial
cells, and on day 11, 15–28% were GFP-positive (Fig. 8c, d).
To test whether upregulation of Ly6a/Sca1 is also observed
in vivo, we analysed Sca1 expression by ﬂow cytometry at
different timepoints after induction of VSMC lineage labelling in
Myh11-CreERt2/EYFP mice. We observed a small but signiﬁcant
increase in the fraction of VSMC-lineage cells that were Sca1-
positive over time, as conﬁrmed by logistic regression (Fig. 8e).
The identiﬁed trend appeared stronger, rather than weaker, when
the confounding effects of animal age were regressed out
(Supplementary Fig. 9), suggesting that it was not due to age-
related differences.
Finally, we tested whether Sca1 upregulation is also a feature of
phenotypic modulation of VSMCs in vivo using a vascular injury
model. Lineage-labelled Myh11-CreERt2/EYFP animals under-
went carotid ligation injury, which results in the acute down-
regulation of contractile genes and activation of proliferation41.
Flow cytometric analysis of dispersed carotid arteries from these
lineage-labelled animals demonstrated that Sca1 expression is
induced in 10-45% of VSMCs (EYFP+) 8 days after ligation
(Fig. 8f–h).
Taken together, these results provide in vitro and in vivo
evidence that VSMCs upregulate Sca1 in response to stimuli such
as culture conditions and vascular injury.
Shared signature of healthy and plaque Sca1+ VSMCs. The
evidence for expanded numbers of Sca1+ medial cells following
vascular injury (Fig. 8f–h) prompted us to investigate this
population in atherosclerotic plaques. To this end, we used
tamoxifen-labelled Myh11-CreERt2/Confetti mice on an ApoE-/-
background, where atherosclerosis is induced by feeding a
cholesterol-rich diet8. We isolated and digested atherosclerotic
plaques and the underlying media from animals after 14-18 weeks
of atherogenic diet and proﬁled the transcriptomes of sorted
Confetti-positive VSMC-lineage cells from these samples with
10X Chromium technology. As shown in the t-SNE plot (Fig. 9a),
most of the VSMC-derived plaque cells formed one large popu-
lation, which could be further subdivided into nine clusters
(clusters 0–8; Fig. 9a). Additionally, a clearly distinct population
(cluster 9; Fig. 9a, pink) was formed by cells expressing macro-
phage markers (e.g., Cd68, Lyz2 and Fcer1g).
In contrast to the low frequency of Sca1-expressing cells
observed in healthy tissue, Ly6a/Sca1 was detected in a signiﬁcant
proportion of VSMC-derived plaque cells (Fig. 9b). Most Ly6a/
Sca1+ cells were contained within cluster 7 (Fig. 9a, lilac),
indicating that Sca1 expression marks a distinct type of VSMC-
derived plaque cells. We next examined whether Sca1-expressing
VSMC-lineage cells in the plaques express the transcriptional
signatures of their Sca1-positive counterparts (S+L+) found in
healthy vessels. We found that cVSMCpos genes associated with
the contractile phenotype were depleted in Sca1+ plaque cells
compared with the majority of the proﬁled cells (Fig. 9c). In
contrast, cVSMCneg genes (associated with response to signals)
showed enrichment in the Sca1-expressing cluster (Fig. 9d). These
results demonstrate that Sca1-positive VSMC-lineage cells from
the plaques share transcriptional features of the rare S+L+ cells
detected in healthy animals.
Notably, cluster 9 (Fig. 9a, pink) and a subpopulation of cells in
the main cluster, which do not express Ly6a/Sca1 (cluster 8;
Fig. 9a, magenta), expressed cVSMCneg genes at higher levels
than most plaque cells, suggesting that these cells could be related
to the Sca1-positive population. Cluster 8 cells express chon-
drocytic genes (Sox9, Ibsp, Chad), consistent with a calcifying
phenotype, whereas cells within cluster 9 have features of
macrophages, as mentioned above. Notably, cVSMCpos genes
were expressed at reduced levels in both of these cell populations
compared with the S+L+ cell population (Fig. 9c, e), which may
reﬂect their further progression away from the contractile state
compared with the Sca1-positive cells.
Previous studies have suggested that the diversity of VSMC-
lineage cells in the atherosclerotic plaque arises from clonal
expansion of either one or very few cells8–10. However, it is not
known whether Sca1-positive and Sca1-negative VSMC-derived
plaque cells coexist in the same clones or, alternatively, arise from
independent clonal origins. To test this directly, we stained
plaques from Myh11-CreERt2/Confetti/ApoE-/- mice fed a
cholesterol-rich diet for Sca1. We found that Sca1 is expressed
in VSMC-derived cells within atherosclerotic lesions (Fig. 9f),
consistent with previous observations42. Sca1-positive Confetti+
cells were located in the core region of the plaque, whereas Sca1
was not detected in the plaque cap (Supplementary Fig. 10). Yet,
the clones that contained Sca1+ Confetti+ cells spanned both the
cap and core regions, suggesting that Sca1-positive and Sca1-
negative VSMC-derived plaque cells originate from a single cell.
Taken together, these results indicate that dynamic modulation of
Sca1 expression in VSMC-lineage cells is a hallmark of plaque
development.
Discussion
In this study, we have delineated VSMC heterogeneity and
identiﬁed the molecular differences that may underlie their
selective clonal expansion in disease8–10. We observe considerable
heterogeneity between VSMCs within and between vascular beds
Fig. 7 Transcriptional signature of S+L+ cells. a Schematic of the experimental strategy. A single-cell suspension of medial cells from Myh11-CreERt2/
Confetti animals (a confocal image of an aortic cryosection is shown) was immunostained for Sca1 and index-sorted based on the expression of the lineage
label and Sca1 to isolate individual cells for Smart-seq2 analysis. b Boxplots showing the log2-transformed normalised levels of Myh11 and Ly6a/Sca1
transcripts detected in Sca1-negative, lineage label positive (S–L+, magenta), Sca1-positive, lineage label positive (S+L+, yellow) and Sca1-positive, lineage
label negative cells (S+L–, blue). c PCA plot summarising the expression of the 500 most variable genes in S−L+, (magenta triangles), S+L+ (yellow
squares) and S+L– (blue circles) cells. d The co-expressed cVSMC network module detected by weighted gene co-expression network analysis (WGCNA)
based on 52 highly variable genes (HVGs) identiﬁed in S+L+ cells. Co-expression strength is indicated by edge thickness. e The PCA plot as in c, with
cVSMC scores for S−L+ (triangles), S+L+ (squares) and S+L- (circles) cells colour-coded on a scale from blue to red. f Heatmap showing the expression
of genes which positively (cVSMCpos, red side strip) or negatively (cVSMCneg, blue side strip) correlated with cVSMC score (likelihood ratio test, fdr-
adjusted p-value < 0.05). Rows represent genes and columns represent cells ordered by their cVSMC score (colour-coded from light to dark purple, lower
strip). g Boxplots showing the expression score of cVSMCpos (left) and cVSMCneg (right) genes for S−L+ (magenta), S+L+ (yellow) and S+L- (blue)
cells. Expression scores are calculated based on PC1 as described in the Methods section. h Bubble plot of selected GO terms enriched in cVSMCpos (left)
and cVSMCneg (right) genes. Dot size represents the number of genes overlapping with each GO term and the adjusted p-value is colour-coded from red
to blue. The full list of enriched GO terms is given in Supplementary Data 9. i Dot plots showing the normalised expression of cVSMCpos gene Myh11 and
cVSMCneg genes Mgp, Col8a1, Igf1, Pak3 and Vcam1 across S+L+ cells, ordered by cVSMC score. Boxplots show median (centre line), ﬁrst and third
quartiles (bounds of box) and 1.5 interquartile range (whiskers) and data for individual cells (dots)
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in healthy animals, and yet ﬁnd that VSMCs uniformly show
hallmarks of their vascular regional identity. We identify a rare
population of Sca1-positive VSMC-lineage cells in healthy vessels
and provide evidence from disease models that Sca1 expression
marks VSMCs undergoing phenotypic switching.
The observed differential expression of transcription factors
and signalling molecules between VSMCs from the aortic arch
versus the descending thoracic aorta suggests distinct gene reg-
ulatory wiring between cells in these regions, which may underlie
the reported regional differences in disease response43. This is
consistent with classical transplantation experiments44 and
ex vivo studies17 showing that gene expression and disease sus-
ceptibility of VSMCs is independent of vascular environment and
growth conditions. In turn, the signiﬁcant within-region VSMC
heterogeneity in expression of genes involved in VSMC biology
and disease, which we report, is consistent with that previously
observed for G-protein coupled receptor expression by single-cell
RT-qPCR45. Such heterogeneity is noteworthy as it indicates the
existence of speciﬁc subsets of cells with particular disease-
relevant properties. Sources of heterogeneity may include further
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Fig. 8 Sca1 is upregulated in response to VSMC stimulation in vitro and in vivo. a Relative expression (log2-transformed) of Myh11 and Ly6a/Sca1 in ex vivo
(black) and cultured mouse aortic VSMCs at passage 4–5 (red) determined by RT-qPCR, normalised to housekeeping gene expression (Hmbs). Lines show
mean from analysis of three independent primary cultures, error bars show s.e.m. Differences inMyh11 (p= 0.001) and Ly6a/Sca1 (p= 5.1e−10) expression
are statistically signiﬁcant (student’s t-test). b The PCA plot of single-cell expression proﬁles for ex vivo VSMCs (squares) and cultured VSMCs (triangles)
shown in Fig. 1e, with expression level of Ly6a/Sca1 colour-coded from light to dark grey. c, d Images (c) and GFP-signal quantiﬁcation (d) of FACS-isolated
medial cells from Sca1-GFP animals (sorted as GFP-negative, n= 4, top row in c) with Sca1-GFP adventitial (Adv, sorted as GFP– or GFP+ (middle row in
c), tissue from four animals was pooled) and wildtype (WT) medial cell controls (sorted as GFP-, n= 1, lower row in c). Cells were cultured for 11 days
before ﬁxation and confocal imaging. c Epiﬂuorescence images showing GFP signal after 3 or 10 days of culture. Scale bars are 100 µm. d Quantiﬁcation of
GFP signal in each population showing the number of GFP-positive cells as a percentage of the total number of DAPI-positive cells. Images for
quantiﬁcation were taken in a single z plane. Individual replicates and their mean are indicated and error bars show s.e.m. e Logistic regression analysis of
the relationship between S+L+ cells and time after lineage labelling (logit-link logistic regression coefﬁcient= 0.016+/−0.005 [mean+/−95%
conﬁdence interval], p-value based on Student’s distribution= 2.56e−10). Trendline and data points, colour-coded by animal age (black gradient), are
shown. Age was not included in the regression model presented here; the model accounting for both time after labelling and age is shown in
Supplementary Fig. 9. f, g FACS plots showing EYFP and Sca1 (APC) expression in cells from the left common carotid artery (LCCA) isolated from
tamoxifen-labelled Myh11-CreERt2/EYFP no injury controls (f) or eight days after ligation (g). h The percentage of lineage labelled cells (EYFP+) that
expressed Sca1 in the LCCA isolated from ligated and no injury controls. Dots represents data from independent animals (n= 5 for each group), lines show
means, and error bars s.e.m
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developmental differences within the VSMC lineage46, differences
in the cells’ microenvironment and haemodynamic stress or
stochastic factors. Analyses focused on individual genes are
required to further investigate the mechanisms and functional
consequences of VSMC heterogeneity in healthy vessels.
We explored the functional relevance of a rare subset of
VSMC-lineage cells that express Sca1, which is encoded by one of
the identiﬁed variably expressed genes (Ly6a/Sca1). We show that
Sca1+ VSMC lineage cells constitute a heterogeneous cell
population. Some of these cells exhibit a contractile VSMC
(cVSMC) signature, as evidenced by expression of cVSMCpos
genes. In contrast, other Sca1+ VSMC lineage cells express
reduced levels of the contractile VSMC signature and instead
manifest a “VSMC response signature” (represented by
cVSMCneg genes), including markers of synthetic VSMCs. We
further demonstrate that the transcriptional proﬁle associated
with these non-conventional Sca1+ VSMC-lineage cells in heal-
thy vessels (VSMC response signatureHigh, cVSMC signatureLow)
is shared by Sca1+ cells within atherosclerotic plaques. We
therefore propose that Sca1+ VSMC-lineage cells within healthy
tissue could represent a more plastic state, which would readily
respond to injury and inﬂammation (Fig. 10). Consistent with
this idea, we show that Sca1 is upregulated in VSMCs upon
exposure to stimuli known to induce phenotypic switching. In
contrast, Sca1 is not expressed in VSMC-derived plaque cells that
display the contractile signature (including cells in the cap). Sca1
is also absent in VSMC-derived plaque cells that have adopted
alternative identities, including those expressing chondrocyte
markers, which nonetheless also display the VSMC response
signature characteristic of Sca1-positive cells. We therefore pro-
pose that Sca1 expression during plaque development could mark
an intermediate VSMCs state, which might give rise to pheno-
typically distinct cells within lesions (Fig. 10).
Sca1-expressing cells in the vessel wall have been reported
previously34. In particular, a medial “side population” isolated on
the basis of reduced Hoechst staining (reﬂecting the expression of
the ABCG2 transporter) was found to be enriched for Sca1-
positive cells32. These “side population” cells expressed low levels
of lineage-speciﬁc marker genes, but upregulated VSMC or
endothelial markers in vitro in response to PDGF-BB/TGF-beta
or VEGF, respectively, indicating an increased plasticity32.
Expression of Abcg2 was detectable in 6/92 of the S+L+ cells we
analysed, suggesting some overlap between these cells and the
“side population”. S+L+ cells also showed increased expression
of some endothelial-associated genes, including Vcam1 and Flt1,
but whether endothelial cell function can be induced in these cells
remains to be tested. Vascular wall-derived Sca1-expressing cells
capable of differentiating into SMCs in vitro and in vivo have also
been detected in the adventitia (AdvSca1)29–31. However, tran-
scriptional proﬁling of a subset of the AdvSca1 cells (marked by
Sonic Hedgehog (Shh)-response gene Gli1) showed expression of
genes that are either not expressed in S+L+ cells (e.g., Eng/Cd105
and Sox2), or that form part of the cVSMC signature, which is
expressed in both S+L+ cells and contractile VSMCs (Smtn,
Tagln, Cnn1, Itgb1)31. Finally, Sca1 is expressed by a population
of angiogenic progenitors residing in the vascular wall34. The
markers of these cells (Pecam1/Cd31, Kit/cKit, Cdh5/VE-Cad-
herin, Eng/Cd105)34 do not form part of the VSMC response
signature identiﬁed in S+L+ cells, but notably, were detected in
many S+L- cells. In conclusion, the transcriptional signature of S
+L+ cells suggests that medial Sca1-expressing cells are distinct
from adventitial and angiogenic progenitor cells. However, fur-
ther analyses are required to comprehensively compare the pre-
viously reported cell populations in the vessel wall with the Sca1+
VSMC-lineage cells detected in our study.
A number of independent lineage tracing experiments have
demonstrated that cells expressing contractile VSMC markers
Fig. 9 The transcriptional signature of S+L+ cells from healthy vessels is expressed in VSMC-derived plaque cells. a t-SNE visualisation of 10X Chromium
dataset (3314 cells) of lineage-positive cells isolated from aortic plaques and the underlying media in Myh11-CreERt2/Confetti mice that were ﬁrst
tamoxifen-treated and then fed a cholesterol-rich diet for 14 or 18 weeks (tissue from three and two animals respectively was pooled for the analysis). The
cells are grouped into a large population composed of 9 clusters, including one enriched for chondrocytic genes (cluster 8, magenta), and a smaller, distinct
population, which was enriched for macrophage genes (cluster 9, pink). b t-SNE plot of 10X Chromium dataset from a with Ly6a/Sca1 expression colour-
coded from light to dark grey. c, d t-SNE plot of 10X Chromium from a, with expression scores for cVSMCpos (c) or cVSMCneg (d) genes colour-coded on
a blue to red gradient. e Violin plots showing the expression score of cVSMCpos genes in cells mapping to each cluster shown in a. f Confocal image of a
cryosection of the descending thoracic aorta from a Myh11-CreERt2/Confetti/ApoE-/- mouse fed a cholesterol-rich diet for 30 weeks and immunostained for
Sca1. Signals for ﬂuorescent Confetti proteins (GFP, green; RFP, red; YFP, yellow and CFP, blue) are shown in i–iii, nuclear DAPI (white) is shown in all
panels, and anti-Sca1 (magenta) is shown in i, ii, and iv. The region outlined in i is magniﬁed in ii–iv, with arrows pointing to cells that are double-positive for
the Confetti lineage label (RFP) and Sca1. Image in i is a maximum projection of 16 z-slices (2 µm each) and ii–iv show a single 2 µm Z-slice. Scale bars are
40 μm (i) or 15 μm (ii–iv)
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Fig. 10 Model of VSMC priming and inﬂammation-induced phenotypic
switching. Within the healthy vessel, priming of contractile VSMCs induces
expression of Sca1 (black symbols) and Response Signature (RS, blue)
genes, as well as the downregulation of the cVSMC signature (cVSMC,
red). We propose that Sca1-expressing VSMC-lineage cells are hyper-
responsive to inﬂammation and constitute an intermediate plastic
population that potentially gives rise to phenotypically distinct, Sca1-
negative VSMC-derived cells in the plaque (cap cells displaying the cVSMC
phenotype, and core cells co-expressing the Response Signature with
chondrocyte- (magenta) or macrophage-like genes (pink))
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(Myh11, Tagln) generate the majority of cells within athero-
sclerotic lesions8–10,38,42,47–49. However, other studies suggest
that specialised Sca1+ progenitor populations also give rise to
vascular lesions30,31,50, possibly alongside VSMCs in a context-
dependent manner51,52. Our observation that a small proportion
of Myh11-lineage labelled VSMCs in healthy vessels express Sca1,
and that Sca1 is upregulated in VSMCs in response to stimula-
tion, may provide an explanation for these apparently discrepant
observations. The co-expression of Sca1 and the VSMC response
signature with the Myh11-lineage label both in healthy vessels
and within plaques suggest that observed Sca1+ cells in vascular
disease models are likely to originate from phenotypically
modulated VSMCs. However, development of speciﬁc, dual-
lineage tracing models is required to examine the functional role
of the previously reported progenitor populations and the S+L+
cells we have identiﬁed here in order to resolve this deﬁnitively.
The hallmarks of VSMC heterogeneity revealed in our study
enable the isolation and functional analysis of speciﬁc VSMC
subpopulations, paving the way for selective targeting of causative
cell populations in vascular disease. In particular, the identiﬁed
VSMC response signature may provide insight into the function
and regulation of disease priming. Our study also highlights
candidate genes for functional testing of how VSMC hetero-
geneity affects the response to inﬂammatory signals in disease
and can be used to identify corresponding plastic cell populations
in humans for targeting and diagnosis. Beyond the immediate
ﬁndings of our study, the single-cell transcriptomes generated
here for the whole aorta and VSMC-lineage cells in healthy
vessels and atherosclerotic plaques will enable further explora-
tions of vascular cell heterogeneity and function.
Methods
Animals and tissue dissection. All experiments were carried out according to the
UK Home Ofﬁce regulations under project licence PPL 70/7565 and have been
approved by the University of Cambridge Ethical Reviews Committee. C57Bl/6
animals were purchased from Charles River. Myh11-CreERt2, Rosa26-Confetti
(Confetti), Rosa26-EYFP (EYFP), ApoE-/-, Sca1-GFP animals have been described
previously8,37,38. Males (the Myh11-CreERt2 transgene is Y-linked) received 10
intraperitoneal injections of 1 mg/ml tamoxifen in corn oil, typically at 6–8 weeks
of age, if not indicated otherwise, for lineage labelling. Aortas from young healthy
male mice (8–14 weeks), unless otherwise indicated, were dissected free of fat and
connective tissue. The aortic arch (AA, the aortal segment from just left of the
branchpoint for the brachiocephalic artery to just right of the branch point for the
left subclavian artery) and descending thoracic (DT, the straight aortal segment
from after the arch has clearly ended until the diaphragm) aortic segments were
isolated and processed separately in experiments comparing vascular regions. The
animals used for analysis of S+L+ cells over time in vivo, were 9-55 weeks of age
and were sacriﬁced 1.6–46.6 weeks post-tamoxifen labelling. For analysis of plaque
cells, Myh11-CreERt2/Confetti/ApoE-/- animals were treated with tamoxifen as
described above and fed a cholesterol rich diet (Special Diets Services, containing
21% fat and 0.2% cholesterol) for 14–18 weeks, starting one week after the last
tamoxifen injection.
Tissue processing, cell staining and ﬂow cytometry. To generate single-cell
suspensions, endothelial cells were removed manually from dissected aortas using a
cotton bud and vessels incubated for 10 min in Collagenase Type IV (1 mg/ml, Life
Technologies) and porcine pancreatic elastase (1 U/ml, Worthington) in DMEM to
allow for separation of the adventitia and medial cell layers. Tissue isolated from 1
to 10 animals was pooled and further digested for 1–2 h to achieve a single-cell
suspension, which was ﬁltered through a 40 μM cell strainer. Single-cell suspen-
sions of medial and adventitial cells were incubated with FcX (1:100, Biolegend) to
block FcRIII binding before staining with APC-conjugated anti-Sca1 (1:10, Mil-
tenyi 130-120-343) or isotype control antibody (1:10, Miltenyi 130-102-655). For
Smart-seq2 experiments, samples were pre-stained with Zombie-NIR (1:100, Bio-
legend) to eliminate dead cells. Stained cells were analysed using Fortessa (Myh11-
CreERt2/Confetti) or C6 (wild-type and Myh11-CreERt2/Rosa26-EYFP) ﬂow
cytometry analysers or index-sorted on an Aria-fusion ﬂow cytometry-assisted cell
sorter (BD Bioscience). The gating strategy is outlined in Supplementary Fig. 11.
Isolation of single cells was veriﬁed by sorting Myh11-CreERt2/Confetti cells
directly into a poly-L-Lysine coated chamber slide followed by cell ﬁxation, DAPI
staining and analysis by confocal microscopy. GFP-positive cells from enzyme
dispersed single-cell suspensions of medial cells from Sca1-GFP transgenic animals
were sorted directly into poly-L-Lysine coated chamber slides and ﬁxed in 4%
paraformaldehyde for 20 min. Cells were washed in PBS and incubated for 1 h with
blocking solution (10% goat serum in 0.1% BSA in PBS) then incubated overnight
at 4 °C with biotin-conjugated anti-aSMA (1:200, Abcam ab125057) in blocking
solution. Cells were then washed in PBS and incubated with streptavidin-
conjugated streptavidin-conjugated Alexa Fluor-647 (1:200, Biolegend 405237 for
one hour, before DAPI nuclear staining and mounting in ProLong Diamond
antifade mountant (Thermo Fisher). In parallel, GFP-negative cells from Sca1-GFP
animals were sorted into 96-well plates and cultured in DMEM with 10% FCS at
37 °C/5% CO2. The cells were observed daily and imaged using an inverted
ﬂuorescence microscope at day 0, day 3, day 6 and day 10. After 11 days of culture,
the cells were ﬁxed, DAPI stained and mounted as described above.
Analysis of Sca1 expression after carotid ligation surgery. Tamoxifen-injected
Myh11-CreERt2/Rosa26-EYFP animals were subjected to carotid ligation
surgery8,41. Animals were anaesthetised using 2.5–3% isoﬂuorane (by inhalation)
and given a pre-operative analgesic (Temgesic). The left common carotid artery
was tied ﬁrmly with one knot using 6-0 silk suture just below the bifurcation point
and animals sacriﬁced 8 days after surgery. The carotid arteries were removed,
dissected free from adipose and connective tissue and whole arteries were digested
as described above until a single-cell suspension was reached. The dissociated cells
were washed once in FACS buffer (1% BSA in PBS), incubated with FcX (1:100,
Biolegend) to block FcRIII binding, stained with APC-conjugated anti-Sca1 (1:10,
Miltenyi 130-120-343) or isotype control antibody (1:10, Miltenyi 130-102-655)
and ﬁltered through a 40 μm cell strainer. Stained cells were analysed on an Aria-
fusion (BD Bioscience) and FlowJo V10 software was used for data analysis and
quantiﬁcation.
Analysis of aortic cryosections. After tissue dissection, aortas were ﬁxed in 4%
paraformaldehyde in PBS for 20 min, followed by overnight cryoprotection in 30%
sucrose in PBS, 1 h incubation in a solution of 50% TissueTek O.C.T in 30%
sucrose in PBS, 1 h incubation in 100% O.C.T and then snap-frozen in O.C.T.
Serial transverse cryosections (12 µm) were then cut onto Superfrost Plus micro-
scope slides, washed in PBS, stained with DAPI at 1 µg/ml in PBS and mounted in
RapiClear 1.52 followed by confocal imaging. Cryosections from the aorta of
animals fed a cholesterol-rich diet were stained for Sca1 before mounting: cryo-
sections were washed in PBS, blocked for 1 h (10% goat serum in 0.1% BSA in
PBS), incubated overnight at 4 °C with anti-Sca1 (1:200, Biolegend 108101) or
Alexa Fluor 647-coupled anti-rat IgG2a (1:200, Biolegend 400526) in blocking
solution, washed in PBS and incubated with Alexa Fluor 647-coupled anti-rat
antibody (1:1000, Abcam ab150167) for one hour, washed in PBS, incubated with
DAPI (1 µg/ml in PBS) to counterstain nuclei and mounted in RapiClear 1.52. For
quantiﬁcation of Confetti signal outside of the medial layer (deﬁned as the area
between the internal and external elastic lamina), four cryosections were analysed
from each of two different parts of three vascular regions (AA, DT and carotid
arteries) of six Myh11-CreERt2/Confetti animals either 1 or 16 weeks after
tamoxifen labelling (three animals per time point, 72 sections in total). No dif-
ference in recombination frequency or detection of Confetti-positive cells in the
endothelial and adventitial layers were detected between the two chase timings.
Imaging and image analysis. Live cultured cells were imaged using an Olympus
IX71 ﬂuorescence microscope with HCImage Live software (Fig. 8c). Confocal
imaging was done using a Leica SP8 with LASX software and a 40x objective
(Figs. 5b, 6b, c, 7a, 9f, Supplementary Fig. 6b and Supplementary Fig. 10) or Zeiss
700 with Zeiss Zen software and a 20x objective (images used for quantiﬁcation in
Fig. 8d). Cell counting and image processing was performed using ImageJ or Imaris
software. Staining intensities in Fig. 5c were calculated from maximum projections
of 14-24 1 µm z-stacks, representative images are shown in Fig. 5b.
Bulk gene expression analysis. Dissected aortas were immediately transferred to
RNAlater followed by isolation of AA and DT segments before manual removal of
the adventitial and endothelial cell layers. The cleaned medial layer from 3 to 5
animals was then lysed in Trizol (Thermo-Fisher) and RNA isolated. For bulk
RNA-seq, the extracted RNA was cleaned on a RNeasy column (Qiagen) and
quality-assessed on a Bioanalyzer (Agilent, RNA integrity number [RIN] 7.8-9).
Sequencing libraries were made from 550 ng total RNA using the TruSeq Stranded
mRNA Library Prep Kit (Illumina) and sequenced using MiSeq (Illumina). In vitro
cultured samples were isolated from enzymatically dispersed VSMCs that had been
cultured for 4–5 passages in DMEM supplemented with 10% foetal calf serum,
glutamine and penicillin. For RT-qPCR analysis, cDNA was synthesised from 0.5
µg RNA using the Quantitect® RT kit (Qiagen) according to the manufacturer’s
instructions. qPCR was performed using SYBR Green PCR master mix (Applied
Biosystems, Life Technologies) and a Rotor-Gene cycler (Qiagen) in duplicate
reactions. Primer sequences are provided in Supplementary Table 1. Quantiﬁcation
was performed relative to a standard curve generated from serial dilutions of
ex vivo whole-aorta cDNA and normalised using the weighted average of house-
keeping genes Hprt1 and Yhwaz or Hmbs.
Analysis of bulk RNA-seq data. Reads were aligned to the GRCm38 mouse
genome using Tophat53 v2.1 and read alignments per gene were counted using
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Seqmonk v1.42 (http://www.bioinformatics.babraham.ac.uk/projects/seqmonk).
Differential gene expression analysis was performed with Bioconductor R package
DESeq254 v1.12. Genes with log2 fold-change > 1 and fdr-adjusted p-value < 0.01
were identiﬁed as differentially expressed.
Single-cell RNA-sequencing. Fluidigm C1: Single-cell suspensions of medial AA
and DT samples from wild type C57BL/6 males (5–7 per experiment) were pre-
pared as described above and processed using a Fluidigm C1 system. Cell sus-
pensions (100 cells/μl) were loaded onto medium-sized (17–25 μm) Auto Prep
Arrays (Fluidigm) and processed according to the manufacturer’s instructions. The
loaded arrays were visually assessed under an inverted microscope to select capture
sites containing a single cell, yielding a 40–70% capture efﬁciency. Cells included in
the analysis were from two independent experiments for each aortic region. Cells
were processed using the SMARTer® Ultra™ Low RNA Kit (Clontech) and
ampliﬁed cDNA was isolated from the arrays.
Smart-seq2: For the analysis of the Sca1+ medial population isolated from
Myh11-CreERt2/Confetti animals, single-cell suspensions of the medial layer from 5
to 7 animals per experiment were prepared and stained as described above.
Individual Sca1+ and control Sca1-negative cells expressing a single Confetti-
lineage label (L+) or Sca1+ cells expressing no Confetti marker (L–) were FACS-
sorted on an Aria-Fusion ﬂow cytometer (BD Bioscience) into separate wells of a
96-well plate. Sca1+ and Sca1– cells were included on the same plate and processed
together to generate ampliﬁed cDNA using the Smart-seq2 protocol carried out as
described previously55, with the following minor modiﬁcations: Primescript
(Clontech) was used for reverse transcription, 24 PCR cycles were used for
ampliﬁcation of cDNA, and ERCC control RNA (Invitrogen) was added
(1:40,000,000 or 1:80,000,000 dilution in RT-mix). The analysed cells were from
three independent experiments using six different medial cell suspensions.
10 Chromium: For analysis of whole aortas, aortas from three tamoxifen-
labelled Myh11-CreERt2/Confetti males were dissected free of fat and connective
tissue and subjected to enzymatic digestion. Single-cell suspensions were pooled,
stained with Zombie-NIR (1:100, Biolegend), ﬁltered through a 40 um ﬁlter and
20,000 singlet, live cells isolated by FACS-sorting on an Aria-Fusion ﬂow cytometer
(BD Bioscience). Note that the Confetti lineage label was not used for sorting. For
analysis of VSMC-lineage labelled cells from healthy vessels, medial single-cell
suspensions from three tamoxifen-labelled Myh11-CreERt2/Confetti males were
generated as described above and FACS sorted on an Aria-Fusion ﬂow cytometer
(BD Bioscience) for expression of live (Zombie-negative), singlets expressing a
single Confetti colour only (gating strategy provided in Supplementary Fig. 11). For
10X Chromium analysis of VSMC-derived atherosclerotic plaque cells, plaques
were manually isolated by dissection from Myh11-CreERt2/Confetti/ApoE-/-
animals that had been tamoxifen labelled and then fed a cholesterol-rich diet for 14
or 18 weeks (as described in Chappell et al.8). Plaques were digested as described56
and plaque cells from two-three animals per time point were pooled and processed
in parallel, ﬁltered through a 40 µm ﬁlter and 20,000 singlet cells expressing a single
Confetti protein isolated by FACS-sorting on an Aria-Fusion ﬂow cytometer (BD
Bioscience) (gating strategy provided in Supplementary Fig. 11, no selection for
Sca1-expression included). Sorted cells were pelleted and resuspended in 35 µl PBS
with 0.05% BSA and loaded onto a 10X Chromium system.
After quality assessment by Bioanalyzer (Agilent) and Quant-iT PicoGreen
(Thermo Fisher) quantiﬁcation, sequencing libraries were prepared from ampliﬁed
cDNA from Fluidigm and Smart-seq2 protocols (approximately 6 ng) using the
Nextera library prep kit (Illumina). Libraries were analysed by paired-end
sequencing on an HiSeq 2500 system (Illumina). Sequencing libraries were directly
generated by the 10X Chromium system and subsequently sequenced on a HiSeq
4000 system.
QC and normalisation of Fluidigm C1 and Smart-seq2 data. Reads were aligned
to the GRCm38 mouse genome using Tophat53 v2.1 and counted using htseq-
count57 v0.8. Single-cell transcriptomes generated with the C1 Fluidigm platform
were quality-controlled based on the total read count (more than 1 million and
fewer than 3.5 million read pairs), the number of genes detected per cell (above
5000 and below 9500), the percentage of reads mapping to genes (more than 80%)
and exons (more than 50%), as well as the percentage of mitochondrial reads (less
than 20%). Single-cell transcriptomes generated using the Smart-seq2 protocol
were quality-controlled based on the total number of reads (more than 100,000)
and genes (more than 1500) detected and the percentage of reads mapping to
ERCC controls (below 30%). Gene-level read counts were normalised using the
computeSumFactors function from the Bioconductor R package scran22 (v1.2 for
Fluidigm C1 data and v1.8 for Smart-seq2 data). For joint PCA analysis of single-
cell and control samples (tube controls), estimateSizeFactorsForMatrix function
from DESeq2 v1.14 (locfunc= shorth) was used for normalisation.
Random forest analysis. Cells were split into training (108 cells; 75%) and test (35
cells; 25%) sets. Recursive feature elimination with 10-fold cross-validation was
performed on the training set using the caret R package (v6.0). This procedure
identiﬁed the 30 most relevant genes, which were then used as features for training
a random forest classiﬁer (number of trees= 1000) with 10 times repeated 10-fold
cross-validation using the randomForest R package v4.6. The R package ROCR
v1.0 was used to generate the ROC plot (Fig. 3d).
Detection of highly variable genes (HVGs). HVG analysis was performed
separately on AA, DT and S+L+ cells. We used a strategy based on variance
decomposition of log-transformed normalised expression counts into technical
variance (learned from data as a function of log-transformed mean count for the
AA and DT cells and estimated using ERCC spike-in controls for S+L+ cells) and
the biological variance of interest, whereby HVGs are deﬁned as genes with the
biological component of variance signiﬁcantly greater than zero. The analysis was
performed using the trendVar and decomposeVar functions in the Bioconductor R
package scran22 (v1.2 for Fluidigm C1 data and v1.8 for Smart-seq2 data). To
obtain robust estimates, we repeated the analysis 1000 times using a 90% subset of
cells for each run. The p-values from the one-tailed HVG tests for each run were
non-independent and so could not be combined using standard methods. We
therefore adopted an approach based on work by Licht and Rubin49, whereby the
p-values for each gene g and run i are transformed into z-scores zg,i using the
quantile function of the standard normal distribution. Gene-level z-scores are then
computed as zg ¼ zg;iTg;i , where zg;i is the mean z-score and Tg,i is the total variance of
z-scores, respectively, across m= 1000 runs for a given gene. The total variance Tg,i
is taken to be:
Tg;i ¼ VarðZiÞ þ VarðZg;iÞ; ð1Þ
and estimated as:
Tg;i ¼ 1þ
1
m 1
Xm
i
ðzg;i  zg;iÞ2; ð2Þ
given that Zi∼N(0,1). The corresponding gene-level p-values are then obtained
from the probability density function of the standard normal distribution and
adjusted for multiple testing using the Benjamini-Hochberg procedure. Genes with
adjusted p-values below 0.05 were considered HVGs. Notably, this approach
produced very similar results to Hartung’s method for combining dependent p-
values58 (as implemented in R package punitroots59 v0.0-2), but yielded more
conservative estimates for genes showing a large variance of HVG test p-values
observed across runs.
We also ranked genes based on the difference between the squared coefﬁcient of
variation (SCV) of their expression values and the median SCV expected given
their sample mean, using an approach proposed by Kolodziejczyk et al25. and
implemented in the function DM in scran22 v1.6.
Annotation of HVGs. The functional annotation of the 147 HVGs identiﬁed using
the variance decomposition-based method in at least one vascular region was
performed based on NCBI PubMed citations listed under the entry for the Mus
musculus reference sequence for each HVG in the NCBI Gene database (https://
www.ncbi.nlm.nih.gov). The identiﬁed citations were manually examined for
experimental evidence of direct regulation of SMC function, cell proliferation, cell
migration, inﬂammation, stem cell properties and/or development of cardiovas-
cular disease (Supplementary Data 4c).
Co-expression analysis and combined gene expression scores. To deﬁne co-
expressed modules among HVGs detected in S+L+ cells, we used weighted cor-
relation network analysis implemented in the R package WGCNA60,61 v1.63.
Speciﬁcally, we used blockwiseModules function with the following parameters:
power= 3, TOMType= “unsigned”, minModuleSize= 5, reassignThreshold= 0,
mergeCutHeight= 0.25, with the soft-thresholding power chosen based on asses-
sing the dependence between it, the scale-free network topology and mean con-
nectivity based on plots produced by pickSoftThreshold. The identiﬁed modules, in
particularly the core VSMC network (ME1) used for expression correlation ana-
lysis, were robust to parameter variation, such as using different soft-thresholding
powers and signed instead of unsigned correlation networks. Network modules in
Fig. 7d and Supplementary Fig. 7c, d were visualised in Cytoscape62 v2.6.1, with
edge thickness proportionate to WGCNA co-expression weight between respective
gene pairs.
Expression of network modules and other gene sets presented in the paper was
summarised by their ﬁrst principal component deﬁned across analysed cells.
Summarised expression of ME1 is referred to as the cVSMC score. Since the signs
of principal components are arbitrary, we additionally set the sign of summarised
expression values such that they positively correlate with the mean expression
values of the respective gene sets across cells.
Detection of genes correlated with the cVSMC network. To detect genes whose
expression correlate (positively or negatively) with the cell’s cVSMC network score
(summarised expression of ME1, see above), we employed an approach taken for
trajectory association analysis in the Bioconductor R package monocle63, with
some modiﬁcations. First, we estimated the mean-variance relationship based on all
genes by ﬁtting a robust local regression to the log-mean normalised counts versus
log-squared coefﬁcient of variation (log-SCV) using the loess function in R (family
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= ”symmetric”). The dependence of normalised expression counts for a given gene
and cell on the cell’s distance along the PC1 axis dt was then assessed by negative
binomial (NB) regression implemented in the R package VGAM64 v1.0-5, whereby
the size parameter of the corresponding NB distribution was assumed to be the
inverse ﬁtted SCV obtained as described above. The signiﬁcance of the regression
ﬁt was assessed by the likelihood-ratio test versus the intercept-only model and the
resulting p-values were adjusted for multiple testing using the Benjamini-Hochberg
procedure. Genes showing adjusted p-values below 0.05 were selected for further
analysis.
Analysis of the 10X Chromium single-cell RNA-seq data. Raw sequencing reads
were processed and aligned to the GRCm38 mouse genome through the 10X
Genomics cellranger pipeline (v2.0 for VSMC-derived plaque cells and v2.1 for
whole aorta cells and VSMC-lineage cells from healthy vessels). Quality control was
performed based on total number of UMI counts per cell (atherosclerotic plaque
dataset >5000 and <20,000, whole aorta/lineage-positive medial cells >1000 and
<8000 UMI counts), genes detected per cell (atherosclerotic plaque dataset >1000
and <5000, whole aorta/lineage-positive medial cells >500 and <2500) and per-
centage of mitochondrial reads per cell (atherosclerotic plaque dataset <9%, whole
aorta/lineage-positive medial cells <8%). Reads from cells passing the quality
control criteria were normalised and scaled using the NormalizeData (scale.factor
= 10,000) and ScaleData functions from the CRAN R package Seurat65 v2.3.1.
Principal component analysis was performed and the ﬁrst ﬁve principal compo-
nents used for clustering and t-distributed Stochastic Neighbour Embedding (t-
SNE)66 visualisation using the Seurat package. Differential gene expression between
clusters was determined using the “tobit” method of the FindMarkers function
implemented in Seurat (padj < 0.05). For identiﬁcation of genes upregulated in
individual VSMC clusters in the analysis of cells from the whole aorta, minimum
log fold change of 0.25 and minimum percentage of expressing cells of 25% were
required for identiﬁcation as an upregulated gene.
Gene ontology analysis. Gene ontology (GO) analysis of genes differentially
expressed between AA and DT cells was carried out using the online Functional
Annotation Clustering tool in The Database for Annotation, Visualisation and
Integrated Discovery (DAVID67 v6.8) for all Biological Processes (BP) terms
against all Mus musculus genes with medium classiﬁcation stringency. Clusters
were ranked by enrichment and fdr-adjusted p-values for the most signiﬁcant term
listed. GO enrichment analysis of genes positively and negatively correlated with
cVSMC network expression was performed based on BP terms using clusterPro-
ﬁler68 package in R v3.8.1. KEGG pathways40 in Supplementary Fig. 8 were
visualised using the R package pathview69 v1.20.
Code availability. R packages were downloaded from CRAN and Bioconductor.
Custom code will be made available upon request.
Data availability
Raw and processed sequencing data is available in the Gene Expression Omnibus
(GEO) repository under accession number GSE117963. Previously published
single-cell proﬁles of cultured VSMCs are available under accession number
GSE79436.
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